Press monitoring
MedImmune to expand flu drug application
10.5.2006 | Press monitoring
Drug maker MedImmune Inc. said it will use new research data to expand an application on file with the Food and Drug Administration for its next-generation inhalable flu vaccine to include children as young as 6 months old.
A biosensor layered like lasagna
10.5.2006 | Press monitoring
In a mixing of pasta metaphors, Pacific Northwest National Laboratory scientists have used electrostatic attraction to layer reactive biological molecules lasagna-like around spaghetti-like carbon nanotubes. This configuration can accommodate a wide range of applications, from ultra-precise blood-sugar monitoring to infectious-agent detection,...
Studies Find Elusive Key to Cell Fate in Embryo
10.5.2006 | Press monitoring
For three billion years, life on earth consisted of single-celled organisms like bacteria or algae. Only 600 million years ago did evolution hit on a system for making multicellular organisms like animals and plants.
Novel Vaccine Curbs Brain Tumor Growth, Increases Survival
10.5.2006 | Press monitoring
A novel vaccine has significantly increased life expectancy in patients with glioblastoma multiforme (GBM), the most dangerous type of brain tumor, a researcher from The University of Texas M. D. Anderson Cancer Center is reporting at the annual meeting of the American Association of Neurological Surgeons (AANS).
Nanotechnology Driving Big Advances in Cancer Imaging
10.5.2006 | Press monitoring
Throughout the history of modern medicine, and particularly clinical oncology, important advances in treating illness and injury have usually followed the development of new ways to better see within the body.
Nano World: Nanotubes as drug-delivery vehicles
9.5.2006 | Press monitoring
Bottling proteins in nanotubes may cause them to unfold, which may drive researchers exploring nanotubes as drug-delivery vehicles to rethink their strategies, experts told UPI's Nano World. These findings could have greater implications when it comes to our understanding of how proteins are assembled by nature's own nanotechnology, the organic...
Genetic Test to Give Clues on Treatment of Hepatitis C
9.5.2006 | Press monitoring
Celera Genomics plans to announce today that it has developed a genetic test it says can help predict which patients with hepatitis C will eventually suffer liver scarring and so are in most need of treatment. The test, which looks at variations in seven genes, represents another step toward personalized medicine, in which treatments are...
Production of polyclonal antisera to manganese superoxide dismutase expressed in downy mildew resistant pearl millet and its application for immunodiagnosis
9.5.2006 | Press monitoring
Level of superoxide dismutase (SOD) in the seedlings of downy mildew resistant pearl millet genotype (IP 18293) increased 3-fold upon inoculation with Sclerospora graminicola. Mn-SOD was purified from pearl millet by ion-exchange and gel filtration chromatography. Polyclonal antibody was raised in rabbit against Mn-SOD of pearl millet....
Immune Response to HIV in the Brain
9.5.2006 | Press monitoring
"As in the rest of the body, in the brain immune cells achieve a level of control of the virus, but are unable to clear the infection," says Howard Fox, associate professor at Scripps Research and director of Scripps NeuroAIDS Preclinical Studies center, who led the study. "Over the long-term, this immune response may act as a double-edged sword,...
Global GM planting to rise 10% this year
9.5.2006 | Press monitoring
MANILA (Dow Jones)--The global land area used for genetically modified crops could rise by at least 10% this year from the previous year's total land area of 90 million hectares, due to growing adoption of biotech crops, the International Service For the Acquisition of Agri-Biotech Applications or ISAAA said Tuesday.
